Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2026)

Agios Pharmaceuticals (AGIO) has 8 years of Inventory Average data on file, last reported at $32.6 million in Q2 2026.

• Quarterly Inventory Average rose 7.92% year-over-year to $32.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $32.6 million (up 7.92% YoY) and the FY2025 annual result came in at $30.3 million, up 29.65% from the prior year.
• Inventory Average eased to $32.6 million in Q2 2026, from $34.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $34.0 million in Q1 2026 to a low of $3.3 million in Q2 2022.
• A 5-year average of $21.1 million and a median of $23.5 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average soared 313.22% — and 2026, when it climbed 7.92%.
• Tracing AGIO's Inventory Average over 5 years: stood at $6.8 million in 2022, then surged by 165.95% to $18.2 million in 2023, then jumped by 48.68% to $27.0 million in 2024, then gained by 20.19% to $32.5 million in 2025, then advanced by 0.44% to $32.6 million in 2026.
• The last three Inventory Average figures came in at $32.6 million (Q2 2026), $34.0 million (Q1 2026), and $32.5 million (Q4 2025), per Business Quant data.